Aytu Bioscience Stock Alpha and Beta Analysis
| AYTU Stock | USD 1.20 0.02 1.64% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aytu BioScience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aytu BioScience over a specified time horizon. Remember, high Aytu BioScience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aytu BioScience's market risk premium analysis include:
Beta 0.4 | Alpha (0.30) | Risk 3.18 | Sharpe Ratio (0.07) | Expected Return (0.21) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aytu |
Aytu BioScience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aytu BioScience market risk premium is the additional return an investor will receive from holding Aytu BioScience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aytu BioScience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aytu BioScience's performance over market.| α | -0.3 | β | 0.40 |
Aytu BioScience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aytu BioScience's Buy-and-hold return. Our buy-and-hold chart shows how Aytu BioScience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Aytu BioScience Market Price Analysis
Market price analysis indicators help investors to evaluate how Aytu BioScience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aytu BioScience shares will generate the highest return on investment. By understating and applying Aytu BioScience stock market price indicators, traders can identify Aytu BioScience position entry and exit signals to maximize returns.
Aytu BioScience Return and Market Media
The median price of Aytu BioScience for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 1.53 with a coefficient of variation of 11.94. The daily time series for the period is distributed with a sample standard deviation of 0.18, arithmetic mean of 1.52, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Liu Vivian H of 6500 shares of Aytu BioScience subject to Rule 16b-3 | 12/26/2024 |
2 | Disposition of 208 shares by Greg Pyszczymuka of Aytu BioScience subject to Rule 16b-3 | 12/31/2024 |
3 | Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 | 01/06/2025 |
4 | Acquisition by Oki Mark K of 90000 shares of Aytu BioScience at 0.23 subject to Rule 16b-3 | 01/17/2025 |
5 | Short Interest in Aytu BioPharma, Inc. Grows By 8.3 | 02/03/2025 |
6 | Aytu BioPharma Inc Q2 2025 Earnings Call Highlights Strong Cash Position and Strategic ... | 02/13/2025 |
7 | Aytu BioPharma Second Quarter 2025 Earnings Beats Expectations | 02/14/2025 |
8 | Acquisition by Joshua Disbrow of 15000 shares of Aytu BioScience at 1.3 subject to Rule 16b-3 | 02/28/2025 |
9 | Acquisition by Christopher Brooke of 7000 shares of Aytu BioScience at 1.73 subject to Rule 16b-3 | 03/04/2025 |
10 | AYTU stock touches 52-week low at 1.23 amid market challenges - Investing.com | 03/07/2025 |
11 | Acquisition by Donofrio John Jr. of 187804 shares of Aytu BioScience subject to Rule 16b-3 | 03/14/2025 |
About Aytu BioScience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aytu or other stocks. Alpha measures the amount that position in Aytu BioScience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 98.34 | 106.42 | 122.38 | 106.07 | PTB Ratio | 0.14 | 0.57 | 3.34 | 3.5 |
Aytu BioScience Upcoming Company Events
As portrayed in its financial statements, the presentation of Aytu BioScience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aytu BioScience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aytu BioScience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aytu BioScience. Please utilize our Beneish M Score to check the likelihood of Aytu BioScience's management manipulating its earnings.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Aytu BioScience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.